Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early compared to other cancers and can quickly develop resistance to chemotherapy — ...

Scientists at the University of Minnesota's Hormel Institute in Austin recently published a study that looked at a drug that ...

Targeting dopamine receptor 2 (DRD2) signaling in combination with temozolomide chemotherapy as a novel therapeutic concept in glioblastomas.

If you or a loved one takes antipsychotics, here are five key facts about tardive dyskinesia—a common, often-overlooked ...

Watching other people tuck into tasty food may trigger overeating, suggests new research. Seeing others enjoying a good feed ...

Access free, up-to-date clinical references on dopamine receptor agonists at Healio. We aid in making confident point-of-care decisions for type 2 diabetes.

Dopamine is a key neurotransmitter known to modulate motivation and reinforcement learning. While the role of dopamine in these reward-related processes is well-established, the cellular and ...

The average American spends 4 hours and 34 minutes daily on their phone. When we’re not glued to our phones, we’re fixated on ...

Dopamine receptors accept the neurotransmitter dopamine, which was recognized in the 1950s. It's been shown to have a specific functional role in the brain.

A new study from the University of Colorado Anschutz Medical Campus has upended decades of neuroscience dogma, revealing that ...

Discover how blocking an opioid receptor could treat dopamine-related disorders without addictive risks, offering new hope for ADHD, ASD and bipolar disorder.